June 24–26, 2027, Rome, Italy

Heart Valve Disease

Heart valve disease represents a diverse spectrum of conditions that pose significant challenges to cardiovascular health. While some cases of valve disease may remain asymptomatic for a long time, others can progress to severe complications, including heart failure. The management of heart valve disease often involves a collaborative effort among cardiologists, cardiac surgeons, and other healthcare professionals. Advances in medical technology have led to the development of less invasive procedures, such as transcatheter aortic valve replacement (TAVR), providing viable options for certain patients who may not be suitable candidates for traditional open-heart surgery. Ongoing research aims to enhance our understanding of the underlying mechanisms of valve disease and explore novel therapeutic approaches. Regular monitoring, early intervention, and personalized treatment plans are crucial elements in the comprehensive care of individuals with heart valve disease, emphasizing the importance of a multidisciplinary and patient-centered approach in addressing the complexities of this cardiovascular condition.

All scientific sessions

Join the Heart Congress 2027 delegation

Rome · June 24–26, 2027· Hybrid · in-person & virtual

Register as Delegate →

Attend without presenting.

Chat with us